Here are relevant reports on : drug-safety-market
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
North America Management System Certification Market by Quality Management System, Occupational Health and Safety, Information Security, IT & Telecom, Data Centers, Food Safety, Environmental Management - Forecast to 2030
The North America management system certification market is projected to grow from USD 11.71 billion in 2025 to USD 13.82 billion by 2030, at a CAGR of 3.37% from 2025 to 2030. The Key Players include SGS SA (Switzerland), Bureau Veritas (France), Intertek Group plc (UK), TÜV SÜD (Germany), TÜV Rheinland (Germany), DNV GL (Norway), UL LLC (US), Applus+ (Spain), CSA Group Testing & Certification Inc. (Canada), and Eurofins Scientific (Luxembourg).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Road Safety Market by Offering (Traffic Control, ANPR, ALPR, Incident Response, Enforcement, Smart Signals, RSUS, Sensors, Cameras, AI, ML, Analytics), Application (Accident Prevention, Work Zone Safety, Violation Management) - Global Forecast to 2030
The road safety market is witnessing strong growth, projected to rise from around USD 6.69 billion in 2025 to over USD 12.39 billion by 2030, registering a CAGR of nearly 13.1%. The major players in the road safety market include Siemens (Germany), Motorola Solutions (US), Jenoptik (Germany), Kapsch TrafficCom (Austria), Sensys Gatso Group (Sweden), Verra Mobility (US), Teledyne FLIR (US), IDEMIA (France), Vitronic (Germany), and SWARCO (Austria).
- Published: July 2025
- Price: $ 7150
- TOC Available:
-
Europe Radiation Detection, Monitoring, and Safety Market By Product (Personal & Area Dosimeters, Material & Full-body Monitors), Component (Gas-filled and Solid-state Detectors), Application (Safety & Security, Diagnostics & Therapy) - Forecast to 2031
The Europe Radiation Detection, Monitoring, and Safety market, valued at USD 0.75 billion in 2025, stood at USD 0.83 billion in 2026 and is projected to advance at a resilient CAGR of 9.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.37 billion by the end of the period. The growth can be attributed to the implementation of strict regulatory mandates, an efficient and well-developed healthcare system, and rising public awareness of occupational and environmental safety in the region.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Protective Eyewear Market by Product Type (Safety Spectacles, Welding Shields, Safety Goggles, Others), Material (Polycarbonate, Glass, Other Material), End-use Industry (Industrial, Healthcare, Defence, Sports), and Region (2025-2030)
The global protective eyewear market size is projected to reach USD 5 billion by 2030 from USD 4 billion in 2024 at a CAGR of 4.5% between 2025 and 2030. 3M Company (US), Honeywell International (US), Uvex Group (Germany), Pyramex Safety Products (US),MCR Safety (US), ANSELL (Australia), Gateway Safety (US) are the key players in the global protective eyewear market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (AntiEpileptic Drugs,AntiArrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
